Smart Asthma Monitoring Device Market Size & Share, by Product (Wearable Monitors, Smart Inhalers, Breath Analyzer, Nebulizers); Device (Cloud-based, AI-based); End-user (Hospitals, Specialty Clinics, Home Care) - Global Supply & Demand Analysis, Growth Forecasts, Statistics Report 2023-2035

  • Report ID: 3918
  • Published Date: Aug 08, 2023
  • Report Format: PDF, PPT

Global Market Size, Forecast, and Trend Highlights Over 2023 - 2035

Smart Asthma Monitoring Device Market size is set to reach USD 2 Billion by the end of 2035, growing at a CAGR of 25% during the forecast period, i.e., 2023-2035. In the year 2022, the industry size of smart asthma monitoring device was around USD 950 Million. The market is predicted to grow with the escalating incorporation of smart inhalers. Smart inhalers are developing as one of the most significant areas of pharmaceutical engagement in digital health. In order to improve the management of asthma and enhance the effectiveness of medication key market players are promoting the use of smart inhalers this is expected to boost the market in the projected period.

Besides, significant market players all across the globe are highly investing in the development of monitoring devices for the enhanced treatment of asthma. One of the key factors driving the growth of the smart asthma monitoring devices sector is the emphasis of these companies on developing products that can help patients and doctors learn more about asthma, improve symptoms and outcomes, and have automated communication for patients and doctors to know what's going on in between visits. In the United States, tens of millions of individuals utilize MDIs. The total quantity of medicine that reaches the lungs can be significantly influenced by techniques like moving the MDI 10-15 times and controlling the sequence and location of breaths. One hundred users of inhalers utilize 90 of them improperly, and 66 forget to take their medication.

Smart Asthma Monitoring Device Market
Get more information on this report: Request Free Sample PDF

Smart Asthma Monitoring Device Sector: Growth Drivers and Challenges

Growth Drivers  

  • Growing Cases of Asthma and COPD Globally – The existence of asthma and COPD diseases are growing rapidly with the increasing geriatric population, growth in the allergic reaction in response to pollen, dust, and other allergens, is leading to the growth in the market. In the year 2020, approx. of 40.7% adults of 18 and above years were diagnosed with asthmatic problems.
  • Rise in Indoor Air Pollutants – As the indoor air gets polluted it leads to harmful respiratory health problems and other chronic health issues, asthma is one of the health problems caused by bad indoor air. Therefore, this raises the demand for smart asthma monitoring devices in the further times. In 2020, indoor air pollution was considered to be the cause of 3.2 million annual deaths, including approximately 237 000 deaths of children under the age of five.
  • Increasing Technological Advancement – Advancements in technology in the healthcare system have led to the emergence of digital devices that aware patients from possible asthma attacks. These instruments contain the capability to monitor adherence, accurately record the time at which patients take a dose and also it offers access to real-time data that needs to be transported to personal device. All these advancements are expected to propel the market growth in the predicted period.


  • Lack of Awareness about the Benefits of Smart Inhalers and Nebulizers - Asthma prevalence is on the rise as a result of increased pollution levels around the world, which has prompted businesses to create high-tech, low-cost monitoring tools to support patients' active commitment to self-monitoring practices. The market for smart asthma monitoring devices is predicted to grow slowly due to a lack of awareness regarding the proper usage of smart inhalers and nebulizers.
  • High Cost of Smart Monitoring Devices
  • Lack of Knowledge about the Device

Smart Asthma Monitoring Device Market: Key Insights

Base Year


Forecast Year

2023 – 2035



Base Year Market Size

~USD 950 million

Forecast Year Market Size

~USD 2 billion

Regional Synopsis

  • North America (U.S., and Canada)
  • Latin America (Mexico, Argentina, Rest of Latin America)
  • Asia-Pacific (Japan, China, India, Indonesia, Malaysia, Australia, Rest of Asia-Pacific)
  • Europe (U.K., Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)
Get more information on this report: Request Free Sample PDF

Smart Asthma Monitoring Device Segmentation

End Users (Hospitals, Specialty Clinics, Home Care)

The hospital segment is expected to hold 40% share of the global smart asthma monitoring device market by the end of 2035. This can be attributed to the increasing demand for hospital-based environments for the treatment of acute serious asthmatic problems and also owing to the high incorporation of smart inhalers for instance dry powdered inhalers and metered dose inhalers.

Moreover, the accessibility of healthcare professionals who offer multiple guidance on the successful handling of monitoring devices is expected to boost the growth of the segment.

Product (Wearable Monitors, Smart Inhalers, Breath Analyzer, Nebulizers)

Smart asthma monitoring device market from the smart inhaler segment is anticipated to observe the largest revenue in the forecast timeframe. With the surge in the integration of smart inhalers in emerging economies, and the escalating demand for smart inhalers that can accurately record the time & monitor adherence and can be digitally connected to the app.

Our in-depth analysis of the global market includes the following segments:


  • Wearable Monitors
  • Smart Inhalers
  • Breath Analyzer
  • Nebulizers


  • Cloud-based
  • AI-based

       End User

  • Hospitals
  • Specialty Clinics
  • Home Care

Want to customize this research report as per your requirements? Our research team will cover the information you require to help you take effective business decisions.

Customize this Report

Smart Asthma Monitoring Device Industry - Regional Synopsis

North American Market Forecast

The smart asthma monitoring device market in North America is estimated to garner the highest market share of 38% in the projected period. The regional market growth can be attributed to the high incidence of asthma in developed nations. According to the Asthma and Allergy Foundation of America (AAFA), over 25 million Americans deal with asthma, including 5.1 million children below the age of 18. 

Healthcare experts believe that asthma is directly related to urbanization, as the urban lifestyle includes more exposure to air pollution, which is among the major causes of high cases of asthma in the U.S.

APAC Market Statistics

In the Asia Pacific region, the smart asthma monitoring device market is expected to grow significantly throughout the projected period. The regional market growth can be estimated on the back of the high geriatric population, along with the rising cases of asthma, as older people are more vulnerable to respiratory diseases, especially in India and China. In China, more than 4.2% population gets affected by asthma which is 45.7 million Chinese adults in which most of whom are old people.

Moreover, the growing adoption of innovative medical equipment in the APAC region is estimated to boost market expansion.

Research Nester
Smart Asthma Monitoring Device Market size
Get more information on this report: Request Free Sample PDF

Companies Dominating the Smart Asthma Monitoring Device Landscape

    • Astellas Pharma Inc.
      • Company Overview
      • Business Strategy
      • Key Product Offerings
      • Financial Performance
      • Key Performance Indicators
      • Risk Analysis
      • Recent Development
      • Regional Presence
      • SWOT Analysis 
    • Adherium Limited
    • AstraZeneca Group
    • Cohero Health, Inc.
    • GlaxoSmithKline plc
    • Aevice Health
    • Vectura Group plc
    • BioTelemetry, Inc.
    • Health Care Originals Inc.
    • Reciprocal Labs Corporation

In the News

  • October 2020: Astellas Pharma Inc. and Iota Biosciences, Inc. announced a merger agreement, following which, Astellas will acquire Iota’s unique bioelectronics technology.
  • July 2019: BioTelemetry acquired ADEA Medical AB, a Swedish medical technology company that provides healthcare services and diagnostic products. This acquisition will expand the portfolio of BioTelemetry to diagnostic products.

Author Credits:  Radhika Gupta, Shivam Bhutani

  • Report ID: 3918
  • Published Date: Aug 08, 2023
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

The growing prevalence of asthma, backed by rapid urbanization is estimated to boost market growth.

The market is anticipated to attain a CAGR of 25% over the forecast period, i.e., 2023 – 2035.

The major players in the market are Adherium Limited, AstraZeneca Group, Cohero Health, Inc., GlaxoSmithKline plc, Aevice Health, Vectura Group plc, Health Care Originals Inc, and others.

The hospital segment is anticipated to garner the largest market size by the end of 2035 and display significant growth opportunities.

The market in North America is projected to hold the largest market share by the end of 2035 and provide more business opportunities in the future.
Smart Asthma Monitoring Device Market Report Scope

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying